Expression of lineage markers and adhesion molecules by B220-lo and B220-neg plasma cells
Lineage marker/adhesion molecule . | B220-lo, %positive . | B220-neg, %positive . | MFI fold change, B220-neg/B220-lo . |
|---|---|---|---|
| CD19 | 61.70 ± 12.76 * | 21.63 ± 13.96 * | 0.39 ± 0.05 |
| CD38 | 49.22 ± 14.41 * | 21.18 ± 7.90 * | 0.45 ± 0.09 |
| MHC class II | 57.08 ± 12.64 * | 19.96 ± 11.24 * | 0.34 ± 0.11 |
| L-selectin | 18.27 ± 0.59 * | 3.08 ± 0.55 * | 0.33 ± 0.10 |
| CD43 (S7) | 87.48 ± 8.39 | 88.32 ± 3.73 | 0.97 ± 0.20 |
| CD43 (S11) | 95.62 ± 2.15 | 97.80 ± 0.98 | 1.20 ± 0.14 |
| CD18 | 96.19 ± 4.71 | 97.08 ± 1.61 | 0.95 ± 0.15 |
| CD11a | 93.43 ± 8.55 | 96.85 ± 1.78 | 1.05 ± 0.14 |
| CD49d | 74.87 ± 11.13 | 81.90 ± 8.60 | 1.05 ± 0.19 |
| PSGL-1 | 77.43 ± 7.17 | 79.81 ± 4.16 | 0.99 ± 0.34 |
| CD44 | 99.64 ± 0.06 | 99.63 ± 0.22 | 1.35 ± 0.42 |
Lineage marker/adhesion molecule . | B220-lo, %positive . | B220-neg, %positive . | MFI fold change, B220-neg/B220-lo . |
|---|---|---|---|
| CD19 | 61.70 ± 12.76 * | 21.63 ± 13.96 * | 0.39 ± 0.05 |
| CD38 | 49.22 ± 14.41 * | 21.18 ± 7.90 * | 0.45 ± 0.09 |
| MHC class II | 57.08 ± 12.64 * | 19.96 ± 11.24 * | 0.34 ± 0.11 |
| L-selectin | 18.27 ± 0.59 * | 3.08 ± 0.55 * | 0.33 ± 0.10 |
| CD43 (S7) | 87.48 ± 8.39 | 88.32 ± 3.73 | 0.97 ± 0.20 |
| CD43 (S11) | 95.62 ± 2.15 | 97.80 ± 0.98 | 1.20 ± 0.14 |
| CD18 | 96.19 ± 4.71 | 97.08 ± 1.61 | 0.95 ± 0.15 |
| CD11a | 93.43 ± 8.55 | 96.85 ± 1.78 | 1.05 ± 0.14 |
| CD49d | 74.87 ± 11.13 | 81.90 ± 8.60 | 1.05 ± 0.19 |
| PSGL-1 | 77.43 ± 7.17 | 79.81 ± 4.16 | 0.99 ± 0.34 |
| CD44 | 99.64 ± 0.06 | 99.63 ± 0.22 | 1.35 ± 0.42 |
Percentage (%) positive and MFI fold change are represented as the mean ± SD determined from 2 to 6 independent experiments for each marker. MFI indicates mean fluorescence intensity.
Statistically significant difference for % positive between B220-lo and B220-neg populations.